New adjuvant permits early pneumococcal immunization in newborn monkeys
Researchers have discovered that newborn monkeys given a single dose of PCV13 along with an experimental adjuvant on the first day of life rapidly developed a strong immunological response against pneumococcal bacteria, giving hope that the same may be true for human newborns. March 23, 2017